Skip to main content
Journal cover image

Achieving Equitable Lung Cancer Screening Implementation in a Texas Safety Net Health System.

Publication ,  Journal Article
Pignone, M; Chang, P; Kluz, N; Altillo, B; Fekete, A; Martinez, A; Medbery, R; Queralt, Y; Shah, K; Vanin, L
Published in: Am J Prev Med
February 2025

INTRODUCTION: A lung cancer screening program using low dose CT (LDCT) in a Federally Qualified Health Center (FQHC) in Central Texas was developed and assessed for equitable implementation. METHODS: From 11/2020-8/2023, patients aged 55-77 years who currently smoked or quit within 15 years with ≥20 pack-years of exposure were identified through EHR query and mailed outreach, or through direct provider referrals. A bilingual social worker confirmed eligibility, provided telecare shared decision-making (SDM), coordinated screening, and offered smoking cessation. To assess equity, LDCT completion across demographics was compared, in 2023. RESULTS: A total of 6,486 patients were mailed outreach materials; 479 patients responded, of whom 108 (22.5%) were eligible and 71 (65.7%) participated in SDM. 629 eligible patients were referred internally; 579 (92.0%) completed SDM. Of the 650 patients who completed SDM, 636 (97.8%) agreed to screening. Mean age was 61.7 years; 38.1% were female. The population was diverse: 35.8% identified as Latino, 17.8% as African American, 26.8% had Medicare or Medicaid, 48.0% used the county medical assistance program, 14.2% were uninsured, and 76.7% currently smoked. Overall, 528 (83.0%) patients completed LDCT. There were no statistically significant differences in completion by age, gender, race/ethnicity, or insurance status. Spanish-speaking patients were more likely to complete the CT than English speakers (OR 2.22, 95% CI=1.22, 4.41) and those who formerly smoked were more likely to complete the CT than patients who currently smoked (OR 1.93, 95% CI=1.12, 3.51). CONCLUSIONS: The navigator-centered program achieved equitable implementation of lung cancer screening in a diverse FQHC system.

Duke Scholars

Published In

Am J Prev Med

DOI

EISSN

1873-2607

Publication Date

February 2025

Volume

68

Issue

2

Start / End Page

227 / 235

Location

Netherlands

Related Subject Headings

  • Tomography, X-Ray Computed
  • Texas
  • Smoking Cessation
  • Safety-net Providers
  • Public Health
  • Middle Aged
  • Mass Screening
  • Male
  • Lung Neoplasms
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pignone, M., Chang, P., Kluz, N., Altillo, B., Fekete, A., Martinez, A., … Vanin, L. (2025). Achieving Equitable Lung Cancer Screening Implementation in a Texas Safety Net Health System. Am J Prev Med, 68(2), 227–235. https://doi.org/10.1016/j.amepre.2024.09.016
Pignone, Michael, Patrick Chang, Nicole Kluz, Brandon Altillo, Andrea Fekete, Amaris Martinez, Rachel Medbery, Yvonne Queralt, Koonj Shah, and LaTasha Vanin. “Achieving Equitable Lung Cancer Screening Implementation in a Texas Safety Net Health System.Am J Prev Med 68, no. 2 (February 2025): 227–35. https://doi.org/10.1016/j.amepre.2024.09.016.
Pignone M, Chang P, Kluz N, Altillo B, Fekete A, Martinez A, et al. Achieving Equitable Lung Cancer Screening Implementation in a Texas Safety Net Health System. Am J Prev Med. 2025 Feb;68(2):227–35.
Pignone, Michael, et al. “Achieving Equitable Lung Cancer Screening Implementation in a Texas Safety Net Health System.Am J Prev Med, vol. 68, no. 2, Feb. 2025, pp. 227–35. Pubmed, doi:10.1016/j.amepre.2024.09.016.
Pignone M, Chang P, Kluz N, Altillo B, Fekete A, Martinez A, Medbery R, Queralt Y, Shah K, Vanin L. Achieving Equitable Lung Cancer Screening Implementation in a Texas Safety Net Health System. Am J Prev Med. 2025 Feb;68(2):227–235.
Journal cover image

Published In

Am J Prev Med

DOI

EISSN

1873-2607

Publication Date

February 2025

Volume

68

Issue

2

Start / End Page

227 / 235

Location

Netherlands

Related Subject Headings

  • Tomography, X-Ray Computed
  • Texas
  • Smoking Cessation
  • Safety-net Providers
  • Public Health
  • Middle Aged
  • Mass Screening
  • Male
  • Lung Neoplasms
  • Humans